Oramed Pharmaceuticals Inc. (NASDAQ:ORMP – Free Report) – Analysts at HC Wainwright decreased their Q3 2024 earnings per share estimates for Oramed Pharmaceuticals in a research report issued on Monday, May 20th. HC Wainwright analyst R. Selvaraju now expects that the biotechnology company will post earnings of ($0.04) per share for the quarter, down from […]
Rathbones Group PLC bought a new stake in shares of Oramed Pharmaceuticals Inc. (NASDAQ:ORMP – Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 289,803 shares of the biotechnology company’s stock, valued at approximately $756,000. Rathbones Group PLC owned approximately 0.72% […]
N.E.W. Advisory Services LLC acquired a new stake in shares of Oramed Pharmaceuticals Inc. (NASDAQ:ORMP – Free Report) during the third quarter, according to its most recent disclosure with the SEC. The fund acquired 12,960 shares of the biotechnology company’s stock, valued at approximately $34,000. A number of other large investors also recently added to […]
Oramed Pharmaceuticals Inc (NASDAQ:ORMP) Expected to Earn Q1 2024 Earnings of $0 02 Per Share theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
StockNews.com upgraded shares of Oramed Pharmaceuticals (NASDAQ:ORMP – Get Rating) from a sell rating to a hold rating in a report issued on Tuesday morning. Other analysts have also recently issued research reports about the stock. Canaccord Genuity Group cut shares of Oramed Pharmaceuticals from a buy rating to a hold rating and cut their […]